TheProfitWatch

ARVN - Arvinas, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
11.01 0.59 (5.31%) 0.0 (-0.04%) 0.0 (-0.04%) 0.16 (1.35%) 0.11 (1.0%) 0.6 (5.41%) 0.0 (0.0%) 0.12 (1.09%)

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.84
Diluted EPS:
-0.84
Basic P/E:
-13.8036
Diluted P/E:
-13.8036
RSI(14) 1m:
74.07
VWAP:
11.59
RVol:

Events

Period Kind Movement Occurred At

Related News